Literature DB >> 1346122

Effects of antihypertensive therapy on insulin resistance.

N M Kaplan1.   

Abstract

In view of the likely prohypertensive effects of hyperinsulinemia and the presence of insulin resistance in primary hypertension, the effects of various antihypertensive therapies on insulin sensitivity need to be identified. The evidence strongly supports major beneficial effects of weight reduction and aerobic exercise. Deleterious effects have been shown for diuretics and most beta-blockers, whereas probable beneficial effects have been seen with alpha-blockers, one angiotensin converting enzyme inhibitor, and various calcium entry blockers. Improvement of insulin sensitivity and reduction of plasma insulin levels are desirable attributes of antihypertensive therapy that should be more carefully considered in the future.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346122     DOI: 10.1161/01.hyp.19.1_suppl.i116

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  3 in total

1.  Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients.

Authors:  Noriyuki Fujii; Kazufumi Tsuchihashi; Hisataka Sasao; Mariko Eguchi; Hideyuki Miurakami; Mamoru Hase; Katsuhiro Higashiura; Satoshi Yuda; Akiyoshi Hashimoto; Tetsuji Miura; Nobuyuki Ura; Kazuaki Shimamoto
Journal:  Heart Vessels       Date:  2008-02-14       Impact factor: 2.037

2.  Cilnidipine and magnesium sulfate supplement ameliorates hyperglycemia, dyslipidemia and inhibits oxidative-stress in fructose-induced diabetic rats.

Authors:  Most Sumaiya Khatun Kali; Md Rafiqul Islam Khan; Ranjan Kumar Barman; Md Farhad Hossain; Mir Imam Ibne Wahed
Journal:  Heliyon       Date:  2021-12-26

3.  Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records.

Authors:  Noboru Kitamura; Yasuo Takahashi; Shuukoh Yamadate; Satoshi Asai
Journal:  Cardiovasc Diabetol       Date:  2007-09-29       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.